Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
AssigneesPresident and Fellows of Harvard College, Children's Medical Center Corporation
InventorsMichael E. GREENBERG, Paul L. Greer
Life of this patent
Estimating the term…
Abstract
Methods for the treatment of Angelman Syndrome autism spectrum disorders are provided. The methods comprise administrating to a subject an agent that increases the expression of, or increases activity of, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) at neuronal synapses.
Claims20
A method for treatment of Angelman Syndrome comprising administrating to a subject an agent that increases the expression of, or increases activity of, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) at neuronal synapses.
A method for treatment of Angelman Syndrome comprising the steps of:
- i) selecting a subject having a maternal deletion of chromosome 15q11-q13 or a loss of function mutation in the E3 ubiquitin ligase gene UBe3A;
- and
- ii) administering an antagonist of metabotropic glutamate receptor subtype 5 (mGluR5) to the subject having Angelman syndrome caused by a the maternal deletion of chromosome 15q11-q13.
Dependencies are inferred from the claim text.